Annals of Oncology 14:ii13-ii16, 2003
© 2003 European Society for Medical Oncology
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases
Centre Hépato-Biliaire, Hopital Paul Brousse, Villejuif, Paris, France
Abstract
Liver metastases concern half of patients with colorectal cancer, and are frequently unresectable, jeopardizing patient outcome. Owing to increased efficacy, chemotherapy can render initially inoperable patients amenable to potentially curative resection. The 34% 5-year and 20% 10-year survival of patients resected following neoadjuvant chronomodulated chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin is similar to that of patients whose disease was operable at diagnosis. Recently, a group of 16 patients were treated with irinotecan and became resectable after treatment. Their survival (56% at 3 years) matches that of patients treated with other forms of chemotherapy. The poor prognosis of patients with non-resectable hepatic metastases might now be improved by the combination of chemotherapy and surgery.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Gruenberger, D. Tamandl, J. Schueller, W. Scheithauer, C. Zielinski, F. Herbst, and T. Gruenberger Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer J. Clin. Oncol., April 10, 2008; 26(11): 1830 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Van Buren II, A. D. Yang, N. A. Dallas, M. J. Gray, S. J. Lim, L. Xia, F. Fan, R. Somcio, Y. Wu, D. J. Hicklin, et al. Effect of Molecular Therapeutics on Liver Regeneration in a Murine Model J. Clin. Oncol., April 10, 2008; 26(11): 1836 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sjovall, F. Granath, B. Cedermark, B. Glimelius, and T. Holm Loco-regional Recurrence from Colon Cancer: A Population-based Study Ann. Surg. Oncol., February 1, 2007; 14(2): 432 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chong and D. Cunningham Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal Cancer J. Clin. Oncol., December 20, 2005; 23(36): 9063 - 9066. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Poston, R. Adam, S. Alberts, S. Curley, J. Figueras, D. Haller, F. Kunstlinger, G. Mentha, B. Nordlinger, Y. Patt, et al. OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer J. Clin. Oncol., October 1, 2005; 23(28): 7125 - 7134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ellis, S. A. Curley, and A. Grothey Surgical Resection After Downsizing of Colorectal Liver Metastasis in the Era of Bevacizumab J. Clin. Oncol., August 1, 2005; 23(22): 4853 - 4855. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Folprecht, A. Grothey, S. Alberts, H.-R. Raab, and C.-H. Kohne Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann. Onc., August 1, 2005; 16(8): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Petrelli, J. Abbruzzese, P. Mansfield, and B. Minsky Hepatic Resection: The Last Surgical Frontier for Colorectal Cancer J. Clin. Oncol., July 10, 2005; 23(20): 4475 - 4477. [Full Text] [PDF]
|
|
|
|
|
|
D. Schrag, M. Weiser, M. Schattner, J. Shia, and T. Akhurst An Increasingly Common Challenge: Management of the Complete Responder With Multi-Focal Metastatic Colorectal Cancer J. Clin. Oncol., March 20, 2005; 23(9): 1799 - 1802. [Full Text] [PDF]
|
|
|
|
|
|
C. J. A. Punt New options and old dilemmas in the treatment of patients with advanced colorectal cancer Ann. Onc., October 1, 2004; 15(10): 1453 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pozzo, M. Basso, A. Cassano, M. Quirino, G. Schinzari, N. Trigila, M. Vellone, F. Giuliante, G. Nuzzo, and C. Barone Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann. Onc., June 1, 2004; 15(6): 933 - 939. [Abstract] [Full Text] [PDF]
|
|